Effectiveness of Copaxone in patients with relapsing-remitting multiple sclerosis

Effectiveness of Copaxone in patients with relapsing-remitting multiple sclerosis

We investigated the effectiveness of Copaxone in patients with relapsing-remitting multiple sclerosis for 3 and 5 years. Significant improvement found the decrease of the frequency of clinical exacerbations and delay the accumulation of physical disability during treatment period.

Detalhes bibliográficos
Principais autores:	V. M. Alifirova, M. A. Titova, A. A. Vereschaka
Formato:	Artigo
Idioma:	English
Publicado em:	Siberian State Medical University (Tomsk) 2010-08-01
coleção:	Бюллетень сибирской медицины
Assuntos:	рассеянный склероз частота обострений балл edss
Acesso em linha:	https://bulletin.ssmu.ru/jour/article/view/1618

Registros relacionados

Copaxone in therapy of remittent disseminated sclerosis patients
por: O. A. Kitcherova, et al.
Publicado em: (2008-09-01)

Epidemiological characteristics of multiple sclerosis in Tomsk Region and their dynamics for last 30 years
por: V. M. Alifirova, et al.
Publicado em: (2012-06-01)

Prospects of laboratory risk evaluation of multiple sclerosis relapse and progressing
por: I. V. Smagina, et al.
Publicado em: (2010-08-01)

ATYPICAL FORMS OF MULTIPLE SCLEROSIS IN THE TOMSK REGION
por: V. M. Alifirova, et al.
Publicado em: (2013-10-01)

Cognitive disturbances in patients with multiple sclerosis
por: V. M. Alifirova, et al.
Publicado em: (2008-09-01)

Apoptosis cells and regulation factors in patients with multiple sclerosis
por: S. A. Vostryakova, et al.
Publicado em: (2009-02-01)

CLINICAL CHARACTERISTICS OF DEBUT AND RISK FACTORS OF PEDIATRIC MULTIPLE SCLEROSIS
por: Валерий Иванович Ларькин, et al.
Publicado em: (2024-11-01)

PREVALENCE AND SEVERITY OF HYPOVITAMINOSIS D IN PATIENTS WITH MULTIPLE SCLEROSIS IN THE SVERDLOVSK REGION
por: E L Turova, et al.
Publicado em: (2012-12-01)

Family case of multiple sclerosis in Perm Region
por: T. V. Zavalina, et al.
Publicado em: (2009-02-01)

Multiple sclerosis prevalence and risk factors among the Altai Region population
por: I. V. Smagina, et al.
Publicado em: (2011-04-01)

The peculiarities of multiple sclerosis clinical course in the South of Russia (on the example of Rostov Region)
por: Z. A. Goncharova
Publicado em: (2009-06-01)

Chronic inflammation and microflora in ENT organs in patients with multiple sclerosis
por: A. V. Teplov, et al.
Publicado em: (2009-06-01)

BIOFEEDBACK: A NEW METHOD FOR CORRECTION OF MOTOR DISORDERS IN PATIENTS WITH MULTIPLE SCLEROSIS
por: Ya. S. Pekker, et al.
Publicado em: (2014-08-01)

Adhesion molecules and proinflammatory cytokines in cerebrospinal fluid of multiple sclerosis patients
por: S. A. Yelchaninova, et al.
Publicado em: (2009-02-01)

Dynamics of quality of life indicators at a multiple sclerosis
por: V. N. Karnaukh, et al.
Publicado em: (2010-08-01)

EFFECT OF NEURODEGENERATIVE CHANGES IN THE BRAIN ON THE FORMATION OF THE DISEASE CLINICAL PICTURE IN PATIENTS WITH MULTIPLE SCLEROSIS
por: L. N. Prakhova, et al.
Publicado em: (2013-06-01)

The basis of membrane stabilized effect of kopaxon in multiple sclerosis
por: L. I. Reikhert, et al.
Publicado em: (2009-02-01)

Polymorphism of chemokine receptor gene CCR5 in multiple sclerosis patients and in healthy subjects in the Siberian region
por: Yu. Yu. Orlova, et al.
Publicado em: (2006-09-01)

IMPROVEMENT METHODS OF DIAGNOSIS THE VISUAL ANALYSER OF PATIENTS WITH MULTIPLE SCLEROSIS
por: A. V. Kovalenko, et al.
Publicado em: (2013-10-01)

Effect of pregnancy on the course of multiple sclerosis
por: A. I. Мuravin, et al.
Publicado em: (2015-12-01)

Neuritis retrobulbaris of multiple sclerosis patients
por: Yu. N. Ignatova, et al.
Publicado em: (2009-06-01)

Investigation of the bone density in multiple sclerosis
por: O. S. Dranichnikova, et al.
Publicado em: (2008-06-01)

Regional cerebral hypoperfusion as a cause of symptoms and progression of multiple sclerosis
por: L. N. Prakhova, et al.
Publicado em: (2020-01-01)

DIAGNOSTIC OPPORTUNITIES OF NEUROOPHTHALMOLOGIC INSPECTION AT RS: ROLE OF AN OPTICAL COHERENT TOMOGRAPHY AND THE VISUAL CAUSED POTENTIALS IN EARLY DIAGNOSTICS OF MULTIPLE SCLEROSIS AND MONITORING OF A CONDITION OF THE VISUAL ANALYZER AT PATIENTS WITH VARIOUS OPTIONS OF MULTIPLE SCLEROSIS
por: Ye. A. Andreyeva
Publicado em: (2013-10-01)

The use of psychodiagnostic methods in the process of psychocorrection cures of a patient with the disseminated sclerosis
por: A. V. Subbotin, et al.
Publicado em: (2009-02-01)

ERECTILE DYSFUNCTION IN MULTIPLE SCLEROSIS
por: Константин Александрович Бурдин, et al.
Publicado em: (2017-09-01)

Rehabilitation potential of patients with myofascial syndrome with peripheral forms of multiple sclerosis
por: Ю.О. Лисенко
Publicado em: (2017-12-01)

ОСОБЕННОСТИ ДЕТСКОГО РАССЕЯННОГО СКЛЕРОЗА
por: Е. V. Onegin, et al.
Publicado em: (2021-07-01)

Some risk management issues in teriflunomide treatment of patients with remitting multiple sclerosis
por: N. Y. Lasch
Publicado em: (2015-12-01)

New therapy prediction technologies in multiple sclerosis
por: V. I. Golovkin, et al.
Publicado em: (2010-08-01)

LEBER'S DISEASE. CLINICAL CASE
por: N. N. Maslova, et al.
Publicado em: (2013-10-01)

SOFTWARE FOR REGIONS OF INTEREST RETRIEVAL ON MEDICAL 3D IMAGES
por: G. G. Stromov, et al.
Publicado em: (2014-08-01)

Questions of management of patients with hard-to-treat remitting multiple sclerosis
por: E. V. Popova, et al.
Publicado em: (2015-12-01)

Comparison study of gut microbiota in case of Parkinson’s disease and other neurological disorders
por: V. A. Petrov, et al.
Publicado em: (2017-01-01)

New features of glatiramer acetate for the treatment of remitting multiple sclerosis
por: N. Y. Lasch
Publicado em: (2015-12-01)

Fingolimod for the treatment of remitting multiple sclerosis: experience of the Moscow Multiple Sclerosis Center (MMSC)
por: E. V. Popova, et al.
Publicado em: (2014-12-01)

Serum prolactin in patients with relapsing remitting multiple sclerosis
por: Hoda A. Alwakil, et al.
Publicado em: (2020-07-01)

Safety and efficacy of fingolimod in Iranian patients with relapsing-remitting multiple sclerosis: An open-label study
por: Rozita Doosti, et al.
Publicado em: (2021-04-01)

Teriflunomide in patients with multiple sclerosis
por: N. Y. Lasch, et al.
Publicado em: (2015-12-01)

Роль нарушений обмена азотистых соединений в патогенезе рассеянного склероза = Role of metabolic disorders of nitrogen compounds in the pathogenesis of multiple sclerosis
por: O. Uy. Naumenko, et al.
Publicado em: (2015-10-01)